{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:05:50Z","timestamp":1795043150715,"version":"4.10.2"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41569-023-00839-5","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T15:05:25Z","timestamp":1676300725000},"page":"495-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["The role of aldehyde dehydrogenase 2 in cardiovascular disease"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3350-745X","authenticated-orcid":false,"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-9125","authenticated-orcid":false,"given":"Yunyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8874-5354","authenticated-orcid":false,"given":"Xiangkai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7253-6563","authenticated-orcid":false,"given":"Jiaojiao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2098-4265","authenticated-orcid":false,"given":"Chang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-4582","authenticated-orcid":false,"given":"Jiali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-5146","authenticated-orcid":false,"given":"Shujian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-8334","authenticated-orcid":false,"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3672-6543","authenticated-orcid":false,"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-1560","authenticated-orcid":false,"given":"Huiyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-3727","authenticated-orcid":false,"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"key":"839_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/10715762.2021.1876856","volume":"55","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation. Free Radic. Res. 55, 405\u2013415 (2021).","journal-title":"Free Radic. Res."},{"key":"839_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.freeradbiomed.2017.04.363","volume":"111","author":"M Xiao","year":"2017","unstructured":"Xiao, M., Zhong, H., Xia, L., Tao, Y. & Yin, H. Pathophysiology of mitochondrial lipid oxidation: role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic. Biol. Med. 111, 316\u2013327 (2017).","journal-title":"Free Radic. Biol. Med."},{"key":"839_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1265\/jjh.71.55","volume":"71","author":"A Matsumoto","year":"2016","unstructured":"Matsumoto, A. Fundamental properties of aldehyde dehydrogenase 2 (ALDH2) and the importance of the ALDH2 polymorphism [Japanese]. Nihon Eiseigaku Zasshi 71, 55\u201368 (2016).","journal-title":"Nihon Eiseigaku Zasshi"},{"key":"839_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ejhg.2011.184","volume":"20","author":"F Takeuchi","year":"2012","unstructured":"Takeuchi, F. et al. Genome-wide association study of coronary artery disease in the Japanese. Eur. J. Hum. Genet. 20, 333\u2013340 (2012).","journal-title":"Eur. J. Hum. Genet."},{"key":"839_CR5","unstructured":"US National Library of Medicine. National Center for Biotechnology Information https:\/\/www.ncbi.nlm.nih.gov\/SNP\/snp_ref.cgi?locusId=217 (2023)."},{"key":"839_CR6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1172\/JCI113875","volume":"83","author":"DW Crabb","year":"1989","unstructured":"Crabb, D. W., Edenberg, H. J., Bosron, W. F. & Li, T. K. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. J. Clin. Invest. 83, 314\u2013316 (1989).","journal-title":"J. Clin. Invest."},{"key":"839_CR7","doi-asserted-by":"publisher","first-page":"251ra118","DOI":"10.1126\/scitranslmed.3009539","volume":"6","author":"VO Zambelli","year":"2014","unstructured":"Zambelli, V. O. et al. Aldehyde dehydrogenase-2 regulates nociception in rodent models of acute inflammatory pain. Sci. Transl. Med. 6, 251ra118 (2014).","journal-title":"Sci. Transl. Med."},{"key":"839_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cvr\/cvq192","volume":"88","author":"CH Chen","year":"2010","unstructured":"Chen, C. H., Sun, L. & Mochly-Rosen, D. Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc. Res. 88, 51\u201357 (2010).","journal-title":"Cardiovasc. Res."},{"key":"839_CR9","doi-asserted-by":"publisher","first-page":"12019","DOI":"10.1021\/bi001221k","volume":"39","author":"J Zhou","year":"2000","unstructured":"Zhou, J. & Weiner, H. Basis for half-of-the-site reactivity and the dominance of the K487 oriental subunit over the E487 subunit in heterotetrameric human liver mitochondrial aldehyde dehydrogenase. Biochemistry 39, 12019\u201312024 (2000).","journal-title":"Biochemistry"},{"key":"839_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","volume":"94","author":"CH Chen","year":"2014","unstructured":"Chen, C. H., Ferreira, J. C., Gross, E. R. & Mochly-Rosen, D. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol. Rev. 94, 1\u201334 (2014).","journal-title":"Physiol. Rev."},{"key":"839_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-981-13-6260-6_3","volume":"1193","author":"CH Chen","year":"2019","unstructured":"Chen, C. H., Ferreira, J. C. B. & Mochly-Rosen, D. ALDH2 and cardiovascular disease. Adv. Exp. Med. Biol. 1193, 53\u201367 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"839_CR12","doi-asserted-by":"publisher","first-page":"dmm049601","DOI":"10.1242\/dmm.049601","volume":"15","author":"CH Chen","year":"2022","unstructured":"Chen, C. H., Kraemer, B. R. & Mochly-Rosen, D. ALDH2 variance in disease and populations. Dis. Model. Mech. 15, dmm049601 (2022).","journal-title":"Dis. Model. Mech."},{"key":"839_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1172\/JCI122064","volume":"129","author":"S Zhong","year":"2019","unstructured":"Zhong, S. et al. Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation. J. Clin. Invest. 129, 252\u2013267 (2019).","journal-title":"J. Clin. Invest."},{"key":"839_CR14","doi-asserted-by":"publisher","first-page":"101919","DOI":"10.1016\/j.redox.2021.101919","volume":"41","author":"S Zhong","year":"2021","unstructured":"Zhong, S. et al. Acetaldehyde dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver. Redox Biol. 41, 101919 (2021).","journal-title":"Redox Biol."},{"key":"839_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155869","volume":"7","author":"L Li","year":"2022","unstructured":"Li, L. et al. Aldehyde dehydrogenase 2 and PARP1 interaction modulates hepatic HDL biogenesis by LXRalpha-mediated ABCA1 expression. JCI Insight 7, e155869 (2022).","journal-title":"JCI Insight"},{"key":"839_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/ATVBAHA.121.317204","volume":"42","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Macrophage ALDH2 (aldehyde dehydrogenase 2) stabilizing Rac2 is required for efferocytosis internalization and reduction of atherosclerosis development. Arterioscler. Thromb. Vasc. Biol. 42, 700\u2013716 (2022).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"839_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.03.018","volume":"71","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function. Free Radic. Biol. Med. 71, 208\u2013220 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"839_CR18","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/j.bbadis.2017.03.016","volume":"1863","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Complex inhibition of autophagy by mitochondrial aldehyde dehydrogenase shortens lifespan and exacerbates cardiac aging. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 1919\u20131932 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"839_CR19","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/eurheartj\/ehaa352","volume":"41","author":"K Yang","year":"2020","unstructured":"Yang, K. et al. Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype. Eur. Heart J. 41, 2442\u20132453 (2020).","journal-title":"Eur. Heart J."},{"key":"839_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","volume":"17","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal, S. & Libby, P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat. Rev. Cardiol. 17, 137\u2013144 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"839_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","volume":"79","author":"L Liberale","year":"2022","unstructured":"Liberale, L. et al. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J. Am. Coll. Cardiol. 79, 837\u2013847 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"839_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13261","volume":"19","author":"C Bose","year":"2020","unstructured":"Bose, C. et al. Sulforaphane prevents age-associated cardiac and muscular dysfunction through Nrf2 signaling. Aging Cell 19, e13261 (2020).","journal-title":"Aging Cell"},{"key":"839_CR23","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.3390\/ijms21144987","volume":"21","author":"S Wu","year":"2020","unstructured":"Wu, S. & Zou, M. H. AMPK, mitochondrial function, and cardiovascular disease. Int. J. Mol. Sci. 21, 4987 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"839_CR24","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","volume":"111","author":"H Yin","year":"2011","unstructured":"Yin, H., Xu, L. & Porter, N. A. Free radical lipid peroxidation: mechanisms and analysis. Chem. Rev. 111, 5944\u20135972 (2011).","journal-title":"Chem. Rev."},{"key":"839_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mam.2018.03.002","volume":"63","author":"CD Ochoa","year":"2018","unstructured":"Ochoa, C. D., Wu, R. F. & Terada, L. S. ROS signaling and ER stress in cardiovascular disease. Mol. Asp. Med. 63, 18\u201329 (2018).","journal-title":"Mol. Asp. Med."},{"key":"839_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/1479-7364-5-4-283","volume":"5","author":"B Jackson","year":"2011","unstructured":"Jackson, B. et al. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum. Genomics 5, 283\u2013303 (2011).","journal-title":"Hum. Genomics"},{"key":"839_CR27","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1021\/bi9521102","volume":"35","author":"AA Klyosov","year":"1996","unstructured":"Klyosov, A. A. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes. Biochemistry 35, 4457\u20134467 (1996).","journal-title":"Biochemistry"},{"key":"839_CR28","doi-asserted-by":"publisher","first-page":"30550","DOI":"10.1074\/jbc.M502345200","volume":"280","author":"HN Larson","year":"2005","unstructured":"Larson, H. N., Weiner, H. & Hurley, T. D. Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase \u201cAsian\u201d variant. J. Biol. Chem. 280, 30550\u201330556 (2005).","journal-title":"J. Biol. Chem."},{"key":"839_CR29","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/j.freeradbiomed.2011.08.002","volume":"51","author":"W Ge","year":"2011","unstructured":"Ge, W., Guo, R. & Ren, J. AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol. Free Radic. Biol. Med. 51, 1736\u20131748 (2011).","journal-title":"Free Radic. Biol. Med."},{"key":"839_CR30","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang, H. & Fu, L. The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment. Acta Pharm. Sin. B 11, 1400\u20131411 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"839_CR31","first-page":"5","volume":"30","author":"HJ Edenberg","year":"2007","unstructured":"Edenberg, H. J. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol. Res. Health 30, 5\u201313 (2007).","journal-title":"Alcohol. Res. Health"},{"key":"839_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1517\/17425255.4.6.697","volume":"4","author":"SA Marchitti","year":"2008","unstructured":"Marchitti, S. A., Brocker, C., Stagos, D. & Vasiliou, V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin. Drug Metab. Toxicol. 4, 697\u2013720 (2008).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"839_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1291\/hypres.25.677","volume":"25","author":"S Takagi","year":"2002","unstructured":"Takagi, S. et al. Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertens. Res. 25, 677\u2013681 (2002).","journal-title":"Hypertens. Res."},{"key":"839_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.atherosclerosis.2010.03.030","volume":"211","author":"YJ Guo","year":"2010","unstructured":"Guo, Y. J. et al. The ALDH2 Glu504Lys polymorphism is associated with coronary artery disease in Han Chinese: relation with endothelial ADMA levels. Atherosclerosis 211, 545\u2013550 (2010).","journal-title":"Atherosclerosis"},{"key":"839_CR35","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/j.1582-4934.2010.01181.x","volume":"15","author":"F Xu","year":"2011","unstructured":"Xu, F. et al. Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome. J. Cell Mol. Med. 15, 1955\u20131962 (2011).","journal-title":"J. Cell Mol. Med."},{"key":"839_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.gene.2013.05.002","volume":"526","author":"H Han","year":"2013","unstructured":"Han, H. et al. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: a meta-analysis. Gene 526, 134\u2013141 (2013).","journal-title":"Gene"},{"key":"839_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/dna.2013.1995","volume":"32","author":"Q Wang","year":"2013","unstructured":"Wang, Q. et al. ALDH2 rs671 polymorphism and coronary heart disease risk among Asian populations: a meta-analysis and meta-regression. DNA Cell Biol. 32, 393\u2013399 (2013).","journal-title":"DNA Cell Biol."},{"key":"839_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2007.03.016","volume":"382","author":"SA Jo","year":"2007","unstructured":"Jo, S. A. et al. A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men. Clin. Chim. Acta 382, 43\u201347 (2007).","journal-title":"Clin. Chim. Acta"},{"key":"839_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003247","volume":"5","author":"Y Mizuno","year":"2016","unstructured":"Mizuno, Y. et al. Variant aldehyde dehydrogenase 2 (ALDH2*2) is a risk factor for coronary spasm and ST-segment elevation myocardial infarction. J. Am. Heart Assoc. 5, e003247 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"839_CR40","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1161\/CIRCULATIONAHA.114.013120","volume":"131","author":"Y Mizuno","year":"2015","unstructured":"Mizuno, Y. et al. East Asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Circulation 131, 1665\u20131673 (2015).","journal-title":"Circulation"},{"key":"839_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1253\/circj.CJ-19-0989","volume":"84","author":"Y Mizuno","year":"2020","unstructured":"Mizuno, Y. et al. East Asians variant mitochondrial aldehyde dehydrogenase 2 genotype exacerbates nitrate tolerance in patients with coronary spastic angina. Circ. J. 84, 479\u2013486 (2020).","journal-title":"Circ. J."},{"key":"839_CR42","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ng.2337","volume":"44","author":"X Lu","year":"2012","unstructured":"Lu, X. et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat. Genet. 44, 890\u2013894 (2012).","journal-title":"Nat. Genet."},{"key":"839_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.4103\/0366-6999.183413","volume":"129","author":"XX Ma","year":"2016","unstructured":"Ma, X. X., Zheng, S. Z., Shu, Y., Wang, Y. & Chen, X. P. Association between carotid intima-media thickness and aldehyde dehydrogenase 2 Glu504Lys polymorphism in Chinese Han with essential hypertension. Chin. Med. J. 129, 1413\u20131418 (2016).","journal-title":"Chin. Med. J."},{"key":"839_CR44","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bjorkegren","year":"2022","unstructured":"Bjorkegren, J. L. M. & Lusis, A. J. Atherosclerosis: recent developments. Cell 185, 1630\u20131645 (2022).","journal-title":"Cell"},{"key":"839_CR45","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"839_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pharmthera.2011.05.008","volume":"132","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. & Ren, J. ALDH2 in alcoholic heart diseases: molecular mechanism and clinical implications. Pharmacol. Ther. 132, 86\u201395 (2011).","journal-title":"Pharmacol. Ther."},{"key":"839_CR47","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/ng.3978","volume":"49","author":"X Lu","year":"2017","unstructured":"Lu, X. et al. Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease. Nat. Genet. 49, 1722\u20131730 (2017).","journal-title":"Nat. Genet."},{"key":"839_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0021-9150(02)00059-X","volume":"164","author":"Y Nakamura","year":"2002","unstructured":"Nakamura, Y. et al. Genetic variation in aldehyde dehydrogenase 2 and the effect of alcohol consumption on cholesterol levels. Atherosclerosis 164, 171\u2013177 (2002).","journal-title":"Atherosclerosis"},{"key":"839_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.atherosclerosis.2016.08.021","volume":"254","author":"Y Tabara","year":"2016","unstructured":"Tabara, Y. et al. Mendelian randomization analysis in three Japanese populations supports a causal role of alcohol consumption in lowering low-density lipid cholesterol levels and particle numbers. Atherosclerosis 254, 242\u2013248 (2016).","journal-title":"Atherosclerosis"},{"key":"839_CR50","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","volume":"19","author":"GJ Koelwyn","year":"2018","unstructured":"Koelwyn, G. J., Corr, E. M., Erbay, E. & Moore, K. J. Regulation of macrophage immunometabolism in atherosclerosis. Nat. Immunol. 19, 526\u2013537 (2018).","journal-title":"Nat. Immunol."},{"key":"839_CR51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C., Yurdagul, A. Jr & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"839_CR52","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbrc.2020.06.075","volume":"529","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress. Biochem. Biophys. Res. Commun. 529, 998\u20131004 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"839_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2019.02.012","volume":"512","author":"S Wei","year":"2019","unstructured":"Wei, S. et al. ALDH2 deficiency inhibits Ox-LDL induced foam cell formation via suppressing CD36 expression. Biochem. Biophys. Res. Commun. 512, 41\u201348 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"839_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/aps.2017.81","volume":"39","author":"MY Yang","year":"2018","unstructured":"Yang, M. Y. et al. Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells. Acta Pharmacol. Sin. 39, 48\u201358 (2018).","journal-title":"Acta Pharmacol. Sin."},{"key":"839_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbrc.2019.03.037","volume":"512","author":"L Xue","year":"2019","unstructured":"Xue, L. et al. Appropriate dose of ethanol exerts anti-senescence and anti-atherosclerosis protective effects by activating ALDH2. Biochem. Biophys. Res. Commun. 512, 319\u2013325 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"839_CR56","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/cbin.11720","volume":"46","author":"Y Bai","year":"2022","unstructured":"Bai, Y. et al. Inhibition of the miR-193b-3p protects against oxidized low-density lipoprotein-induced HUVECs injury by upregulating ALDH2. Cell Biol. Int. 46, 192\u2013202 (2022).","journal-title":"Cell Biol. Int."},{"key":"839_CR57","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/eurheartj\/ehq253","volume":"32","author":"H Ma","year":"2011","unstructured":"Ma, H., Guo, R., Yu, L., Zhang, Y. & Ren, J. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia\/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur. Heart J. 32, 1025\u20131038 (2011).","journal-title":"Eur. Heart J."},{"key":"839_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000779","volume":"3","author":"A Sun","year":"2014","unstructured":"Sun, A. et al. Mitochondrial aldehyde dehydrogenase 2 plays protective roles in heart failure after myocardial infarction via suppression of the cytosolic JNK\/p53 pathway in mice. J. Am. Heart Assoc. 3, e000779 (2014).","journal-title":"J. Am. Heart Assoc."},{"key":"839_CR59","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1126\/science.1158554","volume":"321","author":"CH Chen","year":"2008","unstructured":"Chen, C. H. et al. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321, 1493\u20131495 (2008).","journal-title":"Science"},{"key":"839_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fphar.2016.00101","volume":"7","author":"W Ji","year":"2016","unstructured":"Ji, W. et al. Aldehyde dehydrogenase 2 has cardioprotective effects on myocardial ischaemia\/reperfusion injury via suppressing mitophagy. Front. Pharmacol. 7, 101 (2016).","journal-title":"Front. Pharmacol."},{"key":"839_CR61","doi-asserted-by":"publisher","first-page":"721795","DOI":"10.3389\/fcell.2021.721795","volume":"9","author":"X Zhai","year":"2021","unstructured":"Zhai, X. et al. 4-Hydroxy-2-nonenal promotes cardiomyocyte necroptosis via stabilizing receptor-interacting serine\/threonine-protein kinase 1. Front. Cell Dev. Biol. 9, 721795 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"839_CR62","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.2174\/13816128113199990325","volume":"19","author":"F Fan","year":"2013","unstructured":"Fan, F. et al. MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2. Curr. Pharm. Des. 19, 4865\u20134873 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"839_CR63","first-page":"752","volume":"19","author":"S-P Li","year":"2015","unstructured":"Li, S.-P., Liu, B., Song, B., Wang, C.-X. & Zhou, Y.-C. miR-28 promotes cardiac ischemia by targeting mitochondrial aldehyde dehydrogenase 2 (ALDH2) in mus musculus cardiac myocytes. Eur. Rev. Med. Pharmacol. Sci. 19, 752\u2013758 (2015).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"839_CR64","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1161\/ATVBAHA.115.306012","volume":"35","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Mitochondrial aldehyde dehydrogenase 2 regulates revascularization in chronic ischemia: potential impact on the development of coronary collateral circulation. Arterioscler. Thromb. Vasc. Biol. 35, 2196\u20132206 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"839_CR65","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1053\/euhj.2000.2493","volume":"22","author":"JG Cleland","year":"2001","unstructured":"Cleland, J. G., Khand, A. & Clark, A. The heart failure epidemic: exactly how big is it? Eur. Heart J. 22, 623\u2013626 (2001).","journal-title":"Eur. Heart J."},{"key":"839_CR66","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","volume":"129","author":"AS Go","year":"2014","unstructured":"Go, A. S. et al. Heart disease and stroke statistics \u2014 2014 update: a report from the American Heart Association. Circulation 129, e28\u2013e292 (2014).","journal-title":"Circulation"},{"key":"839_CR67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41371-019-0182-2","volume":"34","author":"CL Xia","year":"2020","unstructured":"Xia, C. L. et al. ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases. J. Hum. Hypertens. 34, 16\u201323 (2020).","journal-title":"J. Hum. Hypertens."},{"key":"839_CR68","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/cvr\/cvu125","volume":"103","author":"KM Gomes","year":"2014","unstructured":"Gomes, K. M. et al. Aldehyde dehydrogenase 2 activation in heart failure restores mitochondrial function and improves ventricular function and remodelling. Cardiovasc. Res. 103, 498\u2013508 (2014).","journal-title":"Cardiovasc. Res."},{"key":"839_CR69","first-page":"3159","volume":"18","author":"Y Hua","year":"2018","unstructured":"Hua, Y. et al. Alda-1, an aldehyde dehydrogenase-2 agonist, improves long-term survival in rats with chronic heart failure following myocardial infarction. Mol. Med. Rep. 18, 3159\u20133166 (2018).","journal-title":"Mol. Med. Rep."},{"key":"839_CR70","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1582-4934.2011.01347.x","volume":"16","author":"W Ge","year":"2012","unstructured":"Ge, W. & Ren, J. mTOR-STAT3-notch signalling contributes to ALDH2-induced protection against cardiac contractile dysfunction and autophagy under alcoholism. J. Cell Mol. Med. 16, 616\u2013626 (2012).","journal-title":"J. Cell Mol. Med."},{"key":"839_CR71","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijcard.2017.11.094","volume":"257","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. ALDH2 protects against alcoholic cardiomyopathy through a mechanism involving the p38 MAPK\/CREB pathway and local renin-angiotensin system inhibition in cardiomyocytes. Int. J. Cardiol. 257, 150\u2013159 (2018).","journal-title":"Int. J. Cardiol."},{"key":"839_CR72","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P. & Netea, M. G. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407\u2013420 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"839_CR73","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-981-13-6260-6_10","volume":"1193","author":"J Pang","year":"2019","unstructured":"Pang, J. et al. The role of ALDH2 in sepsis and the to-be-discovered mechanisms. Adv. Exp. Med. Biol. 1193, 175\u2013194 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"839_CR74","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.bbadis.2019.03.015","volume":"1865","author":"J Pang","year":"2019","unstructured":"Pang, J. et al. Mitochondrial ALDH2 protects against lipopolysaccharide-induced myocardial contractile dysfunction by suppression of ER stress and autophagy. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 1627\u20131641 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"839_CR75","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3892\/mmr.2014.2803","volume":"11","author":"Y Hu","year":"2015","unstructured":"Hu, Y. et al. Mitochondrial aldehyde dehydrogenase activity protects against lipopolysaccharide-induced cardiac dysfunction in rats. Mol. Med. Rep. 11, 1509\u20131515 (2015).","journal-title":"Mol. Med. Rep."},{"key":"839_CR76","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie, R. H. & Abel, E. D. Basic mechanisms of diabetic heart disease. Circ. Res. 126, 1501\u20131525 (2020).","journal-title":"Circ. Res."},{"key":"839_CR77","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/ijerph14020165","volume":"14","author":"GY Li","year":"2017","unstructured":"Li, G. Y. et al. Meta-analysis on the association of ALDH2 polymorphisms and type 2 diabetic mellitus, diabetic retinopathy. Int. J. Env. Res. Public Health 14, 165 (2017).","journal-title":"Int. J. Env. Res. Public Health"},{"key":"839_CR78","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2119\/molmed.2010.00114","volume":"17","author":"J Wang","year":"2011","unstructured":"Wang, J. et al. Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac dysfunction in diabetic rats. Mol. Med. 17, 172\u2013179 (2011).","journal-title":"Mol. Med."},{"key":"839_CR79","doi-asserted-by":"publisher","first-page":"4857921","DOI":"10.1155\/2019\/4857921","volume":"2019","author":"R Cao","year":"2019","unstructured":"Cao, R. et al. ALDH2 overexpression alleviates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation. J. Diabetes Res. 2019, 4857921 (2019).","journal-title":"J. Diabetes Res."},{"key":"839_CR80","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/antiox10030450","volume":"10","author":"HL Lee","year":"2021","unstructured":"Lee, H. L. et al. A Novel ALDH2 activator AD-9308 improves diastolic and systolic myocardial functions in streptozotocin-induced diabetic mice. Antioxidants 10, 450 (2021).","journal-title":"Antioxidants"},{"key":"839_CR81","doi-asserted-by":"publisher","first-page":"10439","DOI":"10.3390\/ijms231810439","volume":"23","author":"G Pan","year":"2022","unstructured":"Pan, G. et al. Aldehyde dehydrogenase 2 activator augments the beneficial effects of empagliflozin in mice with diabetes-associated HFpEF. Int. J. Mol. Sci. 23, 10439 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"839_CR82","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200498R","volume":"36","author":"B Roy","year":"2022","unstructured":"Roy, B., Pan, G., Giri, S., Thandavarayan, R. A. & Palaniyandi, S. S. Aldehyde dehydrogenase 2 augments adiponectin signaling in coronary angiogenesis in HFpEF associated with diabetes. FASEB J. 36, e22440 (2022).","journal-title":"FASEB J."},{"key":"839_CR83","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s00109-016-1449-5","volume":"94","author":"C Wang","year":"2016","unstructured":"Wang, C. et al. Mitochondrial aldehyde dehydrogenase 2 deficiency aggravates energy metabolism disturbance and diastolic dysfunction in diabetic mice. J. Mol. Med. 94, 1229\u20131240 (2016).","journal-title":"J. Mol. Med."},{"key":"839_CR84","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.biopha.2009.12.001","volume":"65","author":"P Zhang","year":"2011","unstructured":"Zhang, P. et al. Inhibition of aldehyde dehydrogenase 2 activity enhances antimycin-induced rat cardiomyocytes apoptosis through activation of MAPK signaling pathway. Biomed. Pharmacother. 65, 590\u2013593 (2011).","journal-title":"Biomed. Pharmacother."},{"key":"839_CR85","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bbadis.2015.12.014","volume":"1862","author":"W Ge","year":"2016","unstructured":"Ge, W., Yuan, M., Ceylan, A. F., Wang, X. & Ren, J. Mitochondrial aldehyde dehydrogenase protects against doxorubicin cardiotoxicity through a transient receptor potential channel vanilloid 1-mediated mechanism. Biochim. Biophys. Acta 1862, 622\u2013634 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"839_CR86","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.yjmcc.2018.07.006","volume":"121","author":"W Liu","year":"2018","unstructured":"Liu, W. et al. Aldehyde dehydrogenase 2 activation ameliorates cyclophosphamide-induced acute cardiotoxicity via detoxification of toxic aldehydes and suppression of cardiac cell death. J. Mol. Cell Cardiol. 121, 134\u2013144 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"839_CR87","doi-asserted-by":"publisher","first-page":"8306","DOI":"10.1073\/pnas.122225199","volume":"99","author":"Z Chen","year":"2002","unstructured":"Chen, Z., Zhang, J. & Stamler, J. S. Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc. Natl Acad. Sci. USA 99, 8306\u20138311 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"839_CR88","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1172\/JCI26564","volume":"116","author":"Y Li","year":"2006","unstructured":"Li, Y. et al. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J. Clin. Invest. 116, 506\u2013511 (2006).","journal-title":"J. Clin. Invest."},{"key":"839_CR89","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000133","volume":"1","author":"S Sakata","year":"2011","unstructured":"Sakata, S. et al. Differential effects of organic nitrates on arterial diameter among healthy Japanese participants with different mitochondrial aldehyde dehydrogenase 2 genotypes: randomised crossover trial. BMJ Open 1, e000133 (2011).","journal-title":"BMJ Open"},{"key":"839_CR90","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1093\/eurheartj\/eht249","volume":"34","author":"T Munzel","year":"2013","unstructured":"Munzel, T., Daiber, A. & Gori, T. More answers to the still unresolved question of nitrate tolerance. Eur. Heart J. 34, 2666\u20132673 (2013).","journal-title":"Eur. Heart J."},{"key":"839_CR91","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1172\/JCI200419267","volume":"113","author":"K Sydow","year":"2004","unstructured":"Sydow, K. et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J. Clin. Invest. 113, 482\u2013489 (2004).","journal-title":"J. Clin. Invest."},{"key":"839_CR92","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCRESAHA.111.245837","volume":"110","author":"M Beretta","year":"2012","unstructured":"Beretta, M. et al. Vascular bioactivation of nitroglycerin is catalyzed by cytosolic aldehyde dehydrogenase-2. Circ. Res. 110, 385\u2013393 (2012).","journal-title":"Circ. Res."},{"key":"839_CR93","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","volume":"120","author":"L Staerk","year":"2017","unstructured":"Staerk, L., Sherer, J. A., Ko, D., Benjamin, E. J. & Helm, R. H. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ. Res. 120, 1501\u20131517 (2017).","journal-title":"Circ. Res."},{"key":"839_CR94","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.yjmcc.2011.09.018","volume":"52","author":"EM Jeong","year":"2012","unstructured":"Jeong, E. M. et al. Metabolic stress, reactive oxygen species, and arrhythmia. J. Mol. Cell Cardiol. 52, 454\u2013463 (2012).","journal-title":"J. Mol. Cell Cardiol."},{"key":"839_CR95","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.hrthm.2022.05.008","volume":"19","author":"J Jin","year":"2022","unstructured":"Jin, J., Chen, J. & Wang, Y. Aldehyde dehydrogenase 2 and arrhythmogenesis. Heart Rhythm. 19, 1541\u20131547 (2022).","journal-title":"Heart Rhythm."},{"key":"839_CR96","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12929-016-0304-x","volume":"23","author":"Y Nakano","year":"2016","unstructured":"Nakano, Y. et al. Genetic variations of aldehyde dehydrogenase 2 and alcohol dehydrogenase 1B are associated with the etiology of atrial fibrillation in Japanese. J. Biomed. Sci. 23, 89 (2016).","journal-title":"J. Biomed. Sci."},{"key":"839_CR97","doi-asserted-by":"publisher","first-page":"6678","DOI":"10.3390\/ijms21186678","volume":"21","author":"LA Hsu","year":"2020","unstructured":"Hsu, L. A. et al. Aldehyde dehydrogenase 2 ameliorates chronic alcohol consumption-induced atrial fibrillation through detoxification of 4-HNE. Int. J. Mol. Sci. 21, 6678 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"839_CR98","doi-asserted-by":"publisher","first-page":"166088","DOI":"10.1016\/j.bbadis.2021.166088","volume":"1867","author":"YF Hu","year":"2021","unstructured":"Hu, Y. F. et al. ALDH2 deficiency induces atrial fibrillation through dysregulated cardiac sodium channel and mitochondrial bioenergetics: a multi-omics analysis. Biochim. Biophys. Acta Mol. Basis Dis. 1867, 166088 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"839_CR99","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1161\/CIRCULATIONAHA.110.952481","volume":"122","author":"K Koda","year":"2010","unstructured":"Koda, K. et al. Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 122, 771\u2013781 (2010).","journal-title":"Circulation"},{"key":"839_CR100","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/jpet.117.241976","volume":"362","author":"A Marino","year":"2017","unstructured":"Marino, A., Sakamoto, T., Robador, P. A., Tomita, K. & Levi, R. S1P receptor 1-mediated anti-renin-angiotensin system cardioprotection: pivotal role of mast cell aldehyde dehydrogenase type 2. J. Pharmacol. Exp. Ther. 362, 230\u2013242 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"839_CR101","doi-asserted-by":"publisher","first-page":"j5842","DOI":"10.1136\/bmj.j5842","volume":"360","author":"RL Morley","year":"2018","unstructured":"Morley, R. L., Sharma, A., Horsch, A. D. & Hinchliffe, R. J. Peripheral artery disease. BMJ 360, j5842 (2018).","journal-title":"BMJ"},{"key":"839_CR102","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ccd.23066","volume":"78","author":"EC Perin","year":"2011","unstructured":"Perin, E. C. et al. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter. Cardiovasc. Interv. 78, 1060\u20131067 (2011).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"839_CR103","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.116.025707","volume":"135","author":"EC Perin","year":"2017","unstructured":"Perin, E. C. et al. Evaluation of cell therapy on exercise performance and limb perfusion in peripheral artery disease: the CCTRN PACE trial (patients with intermittent claudication injected with ALDH bright cells). Circulation 135, 1417\u20131428 (2017).","journal-title":"Circulation"},{"key":"839_CR104","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.redox.2017.05.018","volume":"13","author":"X Sun","year":"2017","unstructured":"Sun, X. et al. Mitochondrial aldehyde dehydrogenase-2 deficiency compromises therapeutic effect of ALDH bright cell on peripheral ischemia. Redox Biol. 13, 196\u2013206 (2017).","journal-title":"Redox Biol."},{"key":"839_CR105","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/stem.2612","volume":"35","author":"SE Sherman","year":"2017","unstructured":"Sherman, S. E. et al. High aldehyde dehydrogenase activity identifies a subset of human mesenchymal stromal cells with vascular regenerative potential. Stem Cell 35, 1542\u20131553 (2017).","journal-title":"Stem Cell"},{"key":"839_CR106","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","volume":"137","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Status of hypertension in China: results from the china hypertension survey, 2012\u20132015. Circulation 137, 2344\u20132356 (2018).","journal-title":"Circulation"},{"key":"839_CR107","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1291\/hypres.24.365","volume":"24","author":"S Takagi","year":"2001","unstructured":"Takagi, S. et al. The aldehyde dehydrogenase 2 gene is a risk factor for hypertension in Japanese but does not alter the sensitivity to pressor effects of alcohol: the Suita study. Hypertens. Res. 24, 365\u2013370 (2001).","journal-title":"Hypertens. Res."},{"key":"839_CR108","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1291\/hypres.30.585","volume":"30","author":"P Hui","year":"2007","unstructured":"Hui, P. et al. Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption. Hypertens. Res. 30, 585\u2013592 (2007).","journal-title":"Hypertens. Res."},{"key":"839_CR109","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4238\/vol10-1gmr1056","volume":"10","author":"T Hasi","year":"2011","unstructured":"Hasi, T., Hao, L., Yang, L. & Su, X. L. Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study. Genet. Mol. Res. 10, 537\u2013543 (2011).","journal-title":"Genet. Mol. Res."},{"key":"839_CR110","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/jhh.2012.15","volume":"27","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Association of a functional single-nucleotide polymorphism in the ALDH2 gene with essential hypertension depends on drinking behavior in a Chinese Han population. J. Hum. Hypertens. 27, 181\u2013186 (2013).","journal-title":"J. Hum. Hypertens."},{"key":"839_CR111","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.bbrc.2016.09.021","volume":"478","author":"K Takashima","year":"2016","unstructured":"Takashima, K. et al. STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation. Biochem. Biophys. Res. Commun. 478, 1764\u20131771 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"839_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11071-w","volume":"7","author":"C Ma","year":"2017","unstructured":"Ma, C. et al. Associations between aldehyde dehydrogenase 2 (ALDH2) rs671 genetic polymorphisms, lifestyles and hypertension risk in Chinese Han people. Sci. Rep. 7, 11136 (2017).","journal-title":"Sci. Rep."},{"key":"839_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177023","volume":"12","author":"Y Wu","year":"2017","unstructured":"Wu, Y. et al. Positive association between ALDH2 rs671 polymorphism and essential hypertension: a case-control study and meta-analysis. PLoS One 12, e0177023 (2017).","journal-title":"PLoS One"},{"key":"839_CR114","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1089\/dna.2019.4647","volume":"38","author":"S Han","year":"2019","unstructured":"Han, S. et al. Acetaldehyde dehydrogenase 2 rs671 polymorphism affects hypertension susceptibility and lipid profiles in a Chinese population. DNA Cell Biol. 38, 962\u2013968 (2019).","journal-title":"DNA Cell Biol."},{"key":"839_CR115","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12872-022-02577-x","volume":"22","author":"H Wu","year":"2022","unstructured":"Wu, H., Huang, Q., Yu, Z. & Zhong, Z. Association of ALDH2 rs671 and MTHFR rs1801133 polymorphisms with hypertension among Hakka people in Southern China. BMC Cardiovasc. Disord. 22, 128 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"key":"839_CR116","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1291\/hypres.25.857","volume":"25","author":"K Amamoto","year":"2002","unstructured":"Amamoto, K. et al. Epidemiologic study of the association of low-Km mitochondrial acetaldehyde dehydrogenase genotypes with blood pressure level and the prevalence of hypertension in a general population. Hypertens. Res. 25, 857\u2013864 (2002).","journal-title":"Hypertens. Res."},{"key":"839_CR117","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/hr.2013.23","volume":"36","author":"WS Zhang","year":"2013","unstructured":"Zhang, W. S. et al. Effect of alcohol and aldehyde dehydrogenase gene polymorphisms on alcohol-associated hypertension: the Guangzhou Biobank Cohort Study. Hypertens. Res. 36, 741\u2013746 (2013).","journal-title":"Hypertens. Res."},{"key":"839_CR118","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/ng.834","volume":"43","author":"N Kato","year":"2011","unstructured":"Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat. Genet. 43, 531\u2013538 (2011).","journal-title":"Nat. Genet."},{"key":"839_CR119","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/hmg\/ddu478","volume":"24","author":"X Lu","year":"2015","unstructured":"Lu, X. et al. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum. Mol. Genet. 24, 865\u2013874 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"839_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050052","volume":"5","author":"L Chen","year":"2008","unstructured":"Chen, L., Smith, G. D., Harbord, R. M. & Lewis, S. J. Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach. PLoS Med. 5, e52 (2008).","journal-title":"PLoS Med."},{"key":"839_CR121","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/jech-2018-211185","volume":"73","author":"PP Zhao","year":"2019","unstructured":"Zhao, P. P. et al. Relationship between alcohol use, blood pressure and hypertension: an association study and a Mendelian randomisation study. J. Epidemiol. Community Health 73, 796\u2013801 (2019).","journal-title":"J. Epidemiol. Community Health"},{"key":"839_CR122","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"N Galie","year":"2015","unstructured":"Galie, N. et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Respir. J. 46, 903\u2013975 (2015).","journal-title":"Eur. Respir. J."},{"key":"839_CR123","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10557-020-07114-6","volume":"36","author":"F Zhang","year":"2022","unstructured":"Zhang, F. et al. Research progress on pulmonary arterial hypertension and the role of the angiotensin converting enzyme 2-angiotensin-(1-7)-mas axis in pulmonary arterial hypertension. Cardiovasc. Drugs Ther. 36, 363\u2013370 (2022).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"839_CR124","doi-asserted-by":"publisher","first-page":"L312","DOI":"10.1152\/ajplung.00074.2012","volume":"303","author":"PW Buehler","year":"2012","unstructured":"Buehler, P. W. et al. Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism. Am. J. Physiol. Lung Cell Mol. Physiol. 303, L312\u2013L326 (2012).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"839_CR125","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.redox.2016.12.019","volume":"11","author":"T Xu","year":"2017","unstructured":"Xu, T. et al. Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension. Redox Biol. 11, 286\u2013296 (2017).","journal-title":"Redox Biol."},{"key":"839_CR126","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1161\/ATVBAHA.119.312946","volume":"39","author":"Y Zhao","year":"2019","unstructured":"Zhao, Y. et al. ALDH2 (aldehyde dehydrogenase 2) protects against hypoxia-induced pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 39, 2303\u20132319 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"839_CR127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.12.003","volume":"95","author":"K Nishida","year":"2016","unstructured":"Nishida, K. & Otsu, K. Autophagy during cardiac remodeling. J. Mol. Cell Cardiol. 95, 11\u201318 (2016).","journal-title":"J. Mol. Cell Cardiol."},{"key":"839_CR128","doi-asserted-by":"publisher","first-page":"2555476","DOI":"10.1155\/2022\/2555476","volume":"2022","author":"S Chang","year":"2022","unstructured":"Chang, S. et al. Aldehyde dehydrogenase 2 (ALDH2) elicits protection against pulmonary hypertension via inhibition of ERK1\/2-mediated autophagy. Oxid. Med. Cell Longev. 2022, 2555476 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"key":"839_CR129","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/eurheartj\/ehab605","volume":"42","author":"H Cui","year":"2021","unstructured":"Cui, H. et al. Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection. Eur. Heart J. 42, 4373\u20134385 (2021).","journal-title":"Eur. Heart J."},{"key":"839_CR130","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jtcvs.2011.07.053","volume":"142","author":"CW Moehle","year":"2011","unstructured":"Moehle, C. W. et al. Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J. Thorac. Cardiovasc. Surg. 142, 1567\u20131574 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"839_CR131","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/CIRCRESAHA.117.311450","volume":"121","author":"G Zhao","year":"2017","unstructured":"Zhao, G. et al. Unspliced XBP1 confers VSMC homeostasis and prevents aortic aneurysm formation via FoxO4 interaction. Circ. Res. 121, 1331\u20131345 (2017).","journal-title":"Circ. Res."},{"key":"839_CR132","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1161\/CIRCRESAHA.117.311819","volume":"121","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. Lactate promotes synthetic phenotype in vascular smooth muscle cells. Circ. Res. 121, 1251\u20131262 (2017).","journal-title":"Circ. Res."},{"key":"839_CR133","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1096\/fj.201902550RRR","volume":"34","author":"SH Tsai","year":"2020","unstructured":"Tsai, S. H. et al. Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells. FASEB J. 34, 9498\u20139511 (2020).","journal-title":"FASEB J."},{"key":"839_CR134","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/eurheartj\/ehaa444","volume":"41","author":"F Bartoli-Leonard","year":"2020","unstructured":"Bartoli-Leonard, F., Saddic, L. & Aikawa, E. Double-edged sword of ALDH2 mutations: one polymorphism can both benefit and harm the cardiovascular system. Eur. Heart J. 41, 2453\u20132455 (2020).","journal-title":"Eur. Heart J."},{"key":"839_CR135","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1212\/WNL.0000000000000707","volume":"83","author":"LL Kilarski","year":"2014","unstructured":"Kilarski, L. L. et al. Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology 83, 678\u2013685 (2014).","journal-title":"Neurology"},{"key":"839_CR136","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1474-4422(15)00338-5","volume":"15","author":"NINDS Stroke Genetics Network (SiGN)International Stroke Genetics, Consortium (ISGC).","year":"2016","unstructured":"NINDS Stroke Genetics Network (SiGN) & International Stroke Genetics, Consortium (ISGC). Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol. 15, 174\u2013184 (2016).","journal-title":"Lancet Neurol."},{"key":"839_CR137","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/NDT.S196175","volume":"15","author":"YL Xu","year":"2019","unstructured":"Xu, Y. L. et al. Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis. Neuropsychiatr. Dis. Treat. 15, 1015\u20131029 (2019).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"839_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02904-4","volume":"19","author":"CH Lin","year":"2021","unstructured":"Lin, C. H. et al. Association of ADH1B polymorphism and alcohol consumption with increased risk of intracerebral hemorrhagic stroke. J. Transl. Med. 19, 227 (2021).","journal-title":"J. Transl. Med."},{"key":"839_CR139","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/cr.2013.69","volume":"23","author":"JM Guo","year":"2013","unstructured":"Guo, J. M. et al. ALDH2 protects against stroke by clearing 4-HNE. Cell Res. 23, 915\u2013930 (2013).","journal-title":"Cell Res."},{"key":"839_CR140","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/cr.2013.76","volume":"23","author":"A Sun","year":"2013","unstructured":"Sun, A. & Ren, J. ALDH2, a novel protector against stroke? Cell Res. 23, 874\u2013875 (2013).","journal-title":"Cell Res."},{"key":"839_CR141","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.7150\/ijbs.38962","volume":"16","author":"P Xia","year":"2020","unstructured":"Xia, P. et al. ALDH 2 conferred neuroprotection on cerebral ischemic injury by alleviating mitochondria-related apoptosis through JNK\/caspase-3 signing pathway. Int. J. Biol. Sci. 16, 1303\u20131323 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"839_CR142","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka, V. et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol. Rev. 64, 520\u2013539 (2012).","journal-title":"Pharmacol. Rev."},{"key":"839_CR143","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s12012-012-9179-6","volume":"12","author":"D Gong","year":"2012","unstructured":"Gong, D. et al. Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury. Cardiovasc. Toxicol. 12, 350\u2013358 (2012).","journal-title":"Cardiovasc. Toxicol."},{"key":"839_CR144","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.yjmcc.2014.01.002","volume":"71","author":"A Sun","year":"2014","unstructured":"Sun, A. et al. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. J. Mol. Cell Cardiol. 71, 92\u2013104 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"839_CR145","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2014.10.140","volume":"179","author":"KM Gomes","year":"2015","unstructured":"Gomes, K. M. et al. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. Int. J. Cardiol. 179, 129\u2013138 (2015).","journal-title":"Int. J. Cardiol."},{"key":"839_CR146","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.bioactmat.2020.12.024","volume":"6","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Alda-1 treatment promotes the therapeutic effect of mitochondrial transplantation for myocardial ischemia-reperfusion injury. Bioact. Mater. 6, 2058\u20132069 (2021).","journal-title":"Bioact. Mater."},{"key":"839_CR147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074050","volume":"8","author":"C Gu","year":"2013","unstructured":"Gu, C. et al. Impaired cardiac SIRT1 activity by carbonyl stress contributes to aging-related ischemic intolerance. PLoS One 8, e74050 (2013).","journal-title":"PLoS One"},{"key":"839_CR148","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/FJC.0000000000000655","volume":"73","author":"Q Yuan","year":"2019","unstructured":"Yuan, Q. et al. ALDH2 Activation inhibited cardiac fibroblast-to-myofibroblast transformation via the TGF-\u03b21\/Smad signaling pathway. J. Cardiovasc. Pharmacol. 73, 248\u2013256 (2019).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"839_CR149","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2147\/TCRM.S88297","volume":"11","author":"X Zhao","year":"2015","unstructured":"Zhao, X. et al. Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt\/\u03b2-catenin signaling pathway. Ther. Clin. Risk Manag. 11, 1371\u20131381 (2015).","journal-title":"Ther. Clin. Risk Manag."},{"key":"839_CR150","doi-asserted-by":"publisher","first-page":"107ra111","DOI":"10.1126\/scitranslmed.3002067","volume":"3","author":"L Sun","year":"2011","unstructured":"Sun, L., Ferreira, J. C. & Mochly-Rosen, D. ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Sci. Transl. Med. 3, 107ra111 (2011).","journal-title":"Sci. Transl. Med."},{"key":"839_CR151","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbadis.2014.05.017","volume":"1852","author":"Y Guo","year":"2015","unstructured":"Guo, Y. et al. A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy. Biochim. Biophys. Acta 1852, 319\u2013331 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"839_CR152","first-page":"2807","volume":"18","author":"T Fang","year":"2018","unstructured":"Fang, T. et al. Alterations in necroptosis during ALDH2-mediated protection against high glucose-induced H9c2 cardiac cell injury. Mol. Med. Rep. 18, 2807\u20132815 (2018).","journal-title":"Mol. Med. Rep."},{"key":"839_CR153","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1600-0773.1949.tb03384.x","volume":"5","author":"J Hald","year":"1949","unstructured":"Hald, J., Jacobsen, E. & Larsen, V. Formation of acetaldehyde in the organism in relation to dosage of antabuse (tetraethylthiuramdisulphide) and to alcohol-concentration in blood. Acta Pharmacol. Toxicol. 5, 179\u2013188 (1949).","journal-title":"Acta Pharmacol. Toxicol."},{"key":"839_CR154","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00395-013-0343-3","volume":"108","author":"H Contractor","year":"2013","unstructured":"Contractor, H. et al. Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models. Basic Res. Cardiol. 108, 343 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"839_CR155","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/j.1530-0277.2010.01390.x","volume":"35","author":"DM Penetar","year":"2011","unstructured":"Penetar, D. M., Maclean, R. R., McNeil, J. F. & Lukas, S. E. Kudzu extract treatment does not increase the intoxicating effects of acute alcohol in human volunteers. Alcohol Clin. Exp. Res. 35, 726\u2013734 (2011).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"839_CR156","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1073\/pnas.90.4.1247","volume":"90","author":"WM Keung","year":"1993","unstructured":"Keung, W. M. & Vallee, B. L. Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase. Proc. Natl Acad. Sci. USA 90, 1247\u20131251 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"839_CR157","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1021\/jm800488j","volume":"51","author":"ED Lowe","year":"2008","unstructured":"Lowe, E. D., Gao, G. Y., Johnson, L. N. & Keung, W. M. Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase. J. Med. Chem. 51, 4482\u20134487 (2008).","journal-title":"J. Med. Chem."},{"key":"839_CR158","doi-asserted-by":"publisher","first-page":"8990","DOI":"10.1073\/pnas.92.19.8990","volume":"92","author":"WM Keung","year":"1995","unstructured":"Keung, W. M., Lazo, O., Kunze, L. & Vallee, B. L. Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism. Proc. Natl Acad. Sci. USA 92, 8990\u20138993 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"839_CR159","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2011.12.042","volume":"678","author":"L He","year":"2012","unstructured":"He, L. et al. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation. Eur. J. Pharmacol. 678, 32\u201338 (2012).","journal-title":"Eur. J. Pharmacol."},{"key":"839_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02805-2","volume":"11","author":"W Li","year":"2020","unstructured":"Li, W. et al. Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling. Cell Death Dis. 11, 599 (2020).","journal-title":"Cell Death Dis."},{"key":"839_CR161","doi-asserted-by":"publisher","first-page":"128045","DOI":"10.1016\/j.bmcl.2021.128045","volume":"43","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts. Bioorg. Med. Chem. Lett. 43, 128045 (2021).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"839_CR162","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/emmm.201303227","volume":"6","author":"T Hosoi","year":"2014","unstructured":"Hosoi, T. et al. Flurbiprofen ameliorated obesity by attenuating leptin resistance induced by endoplasmic reticulum stress. EMBO Mol. Med. 6, 335\u2013346 (2014).","journal-title":"EMBO Mol. Med."},{"key":"839_CR163","doi-asserted-by":"publisher","first-page":"113119","DOI":"10.1016\/j.ejmech.2020.113119","volume":"212","author":"W Tian","year":"2021","unstructured":"Tian, W. et al. The discovery of novel small molecule allosteric activators of aldehyde dehydrogenase 2. Eur. J. Med. Chem. 212, 113119 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"839_CR164","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/1440-1681.12876","volume":"45","author":"WB Jiang","year":"2018","unstructured":"Jiang, W. B. et al. Baicalin protects H9c2 cardiomyocytes against hypoxia\/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2. Clin. Exp. Pharmacol. Physiol. 45, 303\u2013311 (2018).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"839_CR165","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.21037\/atm-20-5838","volume":"8","author":"W Zhang","year":"2020","unstructured":"Zhang, W., Yang, L., Li, L. & Feng, W. Dihydromyricetin attenuates neuropathic pain via enhancing the transition from M1 to M2 phenotype polarization by potentially elevating ALDH2 activity in vitro and vivo. Ann. Transl. Med. 8, 1151 (2020).","journal-title":"Ann. Transl. Med."},{"key":"839_CR166","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1073\/pnas.1220399110","volume":"110","author":"AG Fitzmaurice","year":"2013","unstructured":"Fitzmaurice, A. G. et al. Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proc. Natl Acad. Sci. USA 110, 636\u2013641 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"839_CR167","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0021-9258(18)57033-2","volume":"177","author":"E Racker","year":"1949","unstructured":"Racker, E. Aldehyde dehydrogenase, a diphosphopyridine nucleotide-linked enzyme. J. Biol. Chem. 177, 883\u2013892 (1949).","journal-title":"J. Biol. Chem."},{"key":"839_CR168","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.2042-7158.1951.tb13056.x","volume":"3","author":"WD Graham","year":"1951","unstructured":"Graham, W. D. In vitro inhibition of liver aldehyde dehydrogenase by tetraethylthiuram disulphide. J. Pharm. Pharmacol. 3, 160\u2013168 (1951).","journal-title":"J. Pharm. Pharmacol."},{"key":"839_CR169","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0005-2744(77)90005-5","volume":"483","author":"NJ Greenfield","year":"1977","unstructured":"Greenfield, N. J. & Pietruszko, R. Two aldehyde dehydrogenases from human liver. Isolation via affinity chromatography and characterization of the isozymes. Biochim. Biophys. Acta 483, 35\u201345 (1977).","journal-title":"Biochim. Biophys. Acta"},{"key":"839_CR170","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/BF00283404","volume":"51","author":"HW Goedde","year":"1979","unstructured":"Goedde, H. W., Harada, S. & Agarwal, D. P. Racial differences in alcohol sensitivity: a new hypothesis. Hum. Genet. 51, 331\u2013334 (1979).","journal-title":"Hum. Genet."},{"key":"839_CR171","first-page":"837","volume":"34","author":"C Impraim","year":"1982","unstructured":"Impraim, C., Wang, G. & Yoshida, A. Structural mutation in a major human aldehyde dehydrogenase gene results in loss of enzyme activity. Am. J. Hum. Genet. 34, 837\u2013841 (1982).","journal-title":"Am. J. Hum. Genet."},{"key":"839_CR172","first-page":"205","volume":"8","author":"A Okayama","year":"1994","unstructured":"Okayama, A., Ueshima, H., Yamakawa, M. & Kita, Y. Low-Km aldehyde dehydrogenase deficiency does not influence the elevation of blood pressure by alcohol. J. Hum. Hypertens. 8, 205\u2013208 (1994).","journal-title":"J. Hum. Hypertens."},{"key":"839_CR173","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/eurheartj\/ehs061","volume":"33","author":"H Zhang","year":"2012","unstructured":"Zhang, H., Gong, D. X., Zhang, Y. J., Li, S. J. & Hu, S. Effect of mitochondrial aldehyde dehydrogenase-2 genotype on cardioprotection in patients with congenital heart disease. Eur. Heart J. 33, 1606\u20131614 (2012).","journal-title":"Eur. Heart J."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00839-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00839-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00839-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T09:06:04Z","timestamp":1686819964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00839-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":173,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1038\/s41569-023-00839-5","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"9 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}